23-Chloro-2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4,6,8,10,12(39),13,15,17,19,21,23,25,27,30(37),31,33,35-nonadecaene | 80935-96-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四吡咯及其衍生物
• 英文名称: 23-Chloro-2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4,6,8,10,12(39),13,15,17,19,21,23,25,27,30(37),31,33,35-nonadecaene
• CAS: 80935-96-2
• 化学式: C₃₂H₁₇ClN₈
• 分子量: 549.0
• InChiKey: CJVIJSBNZVSZNE-UHFFFAOYSA-N

物化性质

• 密度：
  1.568±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  41
• 可旋转键数：
  0
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  109
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• SUBSTITUTED ESTRATRIENE DERIVATIVES AS 17BETA HSD INHIBITORS
  申请人：MESSINGER Josef

  公开号：US20080255075A1

  公开（公告）日：2008-10-16

  Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  公式（I）中的替代雌三烯化合物在治疗中很有用，特别是在治疗或抑制需要抑制17β-羟基类固醇脱氢酶（17β-HSD）类型1、类型2和/或类型3酶的类固醇激素依赖性疾病方面，以及它们的盐、含有这种化合物的药物组合物和制备这种化合物的方法。
• GENERAL CATALYST FOR C-H FUNCTIONALIZATION
  申请人：The Board of Trustees of the University of Illinois

  公开号：US20160272662A1

  公开（公告）日：2016-09-22

  The invention provides novel manganese catalysts such as [Mn( t BuPc)], which are general for the amination of all types of C(sp 3 )-H bonds (aliphatic, allylic, propargylic, benzylic, ethereal), including strong 1 o aliphatic C—H bonds, while achieving excellent chemoselectivity, stereospecificity, and high functional group tolerance. We demonstrate the late-stage diversification of bioactive complex molecules that encompass the range of C(sp 3 )-H bond types, such as selective 1 o C—H aminations of betulinic acid and pleuromutilin derivatives. The catalysts' unprecedented balance of reactivity and selectivity is in part attributed to its mechanism of C—H amination that lies between stepwise and concerted.

  该发明提供了新型的锰催化剂，如[Mn(tBuPc)]，适用于所有类型的C(sp3)-H键（脂肪族、烯丙基、丙炔基、苄基、乙醚基）的胺化，包括强1°脂肪族C—H键，同时实现优异的化学选择性、立体特异性和高官能团耐受性。我们展示了包括选择性1°C—H键胺化在内的生物活性复合分子的晚期多样化，这些复合分子涵盖了各种C(sp3)-H键类型，如对苯二酚酸和普鲁莫铁霉素衍生物的选择性1°C—H键胺化。催化剂在反应性和选择性之间的前所未有的平衡部分归因于其C—H键胺化机制介于逐步和协同之间。
• ORGANIC PHOTOVOLTAIC-BATTERY HYBRID DEVICE
  申请人：Frazier Rachel M.

  公开号：US20120318348A1

  公开（公告）日：2012-12-20

  Photoactive layers for use in a photovoltaic cell are described. The photoactive layers comprise at least one photoactive ion paired with another ion. This photoactive ion pair can be in the form of an ionic liquid, hydrogen bonded ion pair, cocrystal, or complex to allow for greater flexibility and portability. Also described are photovoltaic cells that contain the described photoactive layers sandwiched between two electrodes.

  描述了用于光伏电池的光活性层。光活性层包括至少一种与另一种离子配对的光活性离子。这种光活性离子对可以采用离子液体、氢键离子对、共晶或复合物的形式，以实现更大的灵活性和便携性。还描述了包含所述光活性层的光伏电池，夹在两个电极之间。
• [EN] OXIDATION OF 2-MERCAPTOETHANOL<br/>[FR] OXYDATION DU 2-MERCAPTOÉTHANOL
  申请人：BASF SE

  公开号：WO2015086565A1

  公开（公告）日：2015-06-18

  The present invention relates to a process for the preparation of bis-(2-hydroxyethyl)-disulfide by oxidizing 2-mercaptoethanol with oxygen in a reaction mixture comprising at least one ho- mogeneously distributed iron comprising salt or complex as catalyst and at least one tertiary amine, to bis-(2-hydroxyethyl)-disulfide, obtainable with the process, and to the use of this bis- (2-hydroxyethyl)-disulfide as intermediate in the manufacture of chemical compounds, such as lubricant additives and in the tertiary oil recovery.

  本发明涉及一种制备双-(2-羟乙基)-二硫化物的方法，该方法通过将2-巯基乙醇与氧气在反应混合物中氧化，其中该混合物包括至少一种均匀分布的铁盐或配合物作为催化剂和至少一种三级胺，得到的产物为双-(2-羟乙基)-二硫化物。本发明还涉及将该双-(2-羟乙基)-二硫化物作为化学化合物的中间体用于制造润滑剂添加剂和三级油回收等方面的用途。
• [EN] SOLUTION COMPRISING FLUORESCENT DYE AS FIDUCIAL MARKER<br/>[FR] SOLUTION COMPRENANT UN MARQUEUR FLUORESCENT EN TANT QUE MARQUEUR DE RÉFÉRENCE
  申请人：UNIV DANMARKS TEKNISKE

  公开号：WO2019243422A1

  公开（公告）日：2019-12-26

  The present disclosure relates to a solution comprising a water insoluble carbohydrate and a fluorescent dye, such as a near infrared (NIR) contrast agent, wherein the solution sets under aqueous conditions, such as in vivo, to form e.g. a gel, a glass, a semi-solid, a solid, a crystal or any mixtures thereof. The disclosure further relates to preparation of such solution and use of such solution for in vivo imaging and/or guidance of surgery or interventional therapeutic procedures.

  本公开涉及一种溶液，包括一种水不溶性碳水化合物和一种荧光染料，例如一种近红外（NIR）对比剂，其中该溶液在水性条件下，例如在体内，形成例如凝胶、玻璃、半固体、固体、晶体或其任何混合物。该公开进一步涉及制备这种溶液和使用这种溶液进行体内成像和/或手术或介入治疗程序的指导。